Failure to Monitor Long-Term Antibiotic Use
Summary
The facility failed to implement an effective Infection Control Surveillance process for monitoring and tracking long-term antibiotic usage, specifically for a resident who was on an antibiotic as a preventative measure for chronic urinary tract infections (UTIs). The facility's Infection Prevention and Control Program and Antibiotic Stewardship Program Policy outlined the need for monitoring antibiotic use, including tracking antibiotic starts, adherence to evidence-based criteria, and reviewing resistance patterns. However, the facility did not have a system in place to track or monitor long-term antibiotic use, which was evident in the case of Resident #17, who was on Macrobid for long-term use without proper documentation or tracking. Resident #17, who had a history of UTIs, was moderately cognitively impaired and had memory problems. The resident was prescribed Macrobid for candidiasis, but the diagnosis was incorrect, as Macrobid is not indicated for fungal infections. The resident's medical records lacked documentation of a Situation-Background-Assessment-Recommendation (SBAR) or McGreer Criteria related to the antibiotic use. Interviews with facility staff, including the Infection Control Preventionist (ICP), Licensed Practical Nurse (LPN), and Assistant Director of Nursing (ADON), revealed that there was no monthly review or reassessment of long-term antibiotic use, and the facility did not track such usage as part of their infection control surveillance. The Director of Nursing (DON) confirmed that the ICP was responsible for the Infection Control Surveillance and monitoring of the antibiotic stewardship program but did not track long-term antibiotic use. The facility's surveillance only documented new antibiotic usage and infections monthly. The resident was on Macrobid upon admission for long-term preventative management of UTIs due to colonized bacteria, but the facility did not include this in their monitoring. The DON also noted that a diagnosis of fungal infection was not an acceptable use for Macrobid, and the pharmacy's monthly drug regimen review was expected to ensure correct use and diagnosis for all medications.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.